OKYO Pharma (NASDAQ: $OKYO), a clinical stage biopharmaceutical company, announced a major stability milestone for its drug candidate urcosimod on Monday, March 31, 2025. Details […]
Category: Sponsored
Hoth Therapeutics (NASDAQ: HOTH) Unveils Plan To Submit HT-001 Expanded Access Application Amid Double Digit Growth in The Past Week: What To Know About Hoth
Hoth Therapeutics (NASDAQ: $HOTH), a clinical-stage biopharmaceutical working to develop innovative therapies, announced on Monday, March 10, 2025, that it planned to submit an Expanded […]
Aditxt (NASDAQ: ADTX) Subsidiary Pearsanta Prepares For IPO To Drive Launch Of Early Cancer Detection And Diagnosis Test in $31B Market
Aditxt (NASDAQ: $ADTX) announced on Friday, February 21, 2025, that its Subsidiary, Pearsanta, had engaged the services of a lead underwriter as it prepares for […]
Tiziana Life Sciences (NASDAQ: TLSA) Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program Amid Strong Momentum: Is TLSA Poised For A Major Breakout?
Tiziana Life Sciences (NASDAQ: $TLSA) is a biotech firm, which is working on comprehensive research efforts to advance novel treatments, and improve patient outcome with […]
Tiziana Life Sciences (NASDAQ: TLSA) Shows Great Promise With Intranasal Foralumab For Alzheimer’s Treatment
Tiziana Life Sciences (NASDAQ: $TLSA) is a biotech firm pushing the boundaries in the discovery and development of novel molecules to treat human diseases. On […]
La Rosa Holdings (NASDAQ: LRHC) Strengthens Finances By Redeeming Outstanding Warrants Amid Planned Interview With Zack Morris
La Rosa Holdings (NASDAQ: LRHC) is a holding company for six agent-focussed multi-service real estate segments. On Tuesday, January 28, 2025, the company revealed that […]